Showing results (2061-2070 of 5,275) with videos related to
Sort By:
Pageof 528
Oncology|March 3, 2005
Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancerC N Sternberg, P Whelan, J Hetherington, et al.Oncology|September 17, 2005
Detecting normal cell radiosensitivity via assay of DNA damage in lymphocytes for individualizing radiotherapy in head and neck cancer patientsWei-Dong Wang, Zheng-Tang Chen, De-Zhi Li, et al.Oncology|September 17, 2005
Primary breast lymphoma: results of a controlled clinical trialAgustin Avilés, Serafin Delgado, M Jesús Nambo, et al.Oncology|September 6, 2005
Establishment and characterization of a pancreatic carcinoma cell line derived from malignant pleural effusionA N Starr, A Vexler, S Marmor, et al.Oncology|July 16, 2005
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancerM Karthaus, Harald Ballo, Wolgang Abenhardt, et al.Oncology|July 16, 2005
Weekly docetaxel in pretreated metastatic breast cancer patients: a phase I-II studyCecilia Nisticò, Francesco Cognetti, Luciano Frontini, et al.Oncology|July 16, 2005
Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancerGianfilippo Bertelli, Ornella Garrone, Laura Bertolotti, et al.Oncology|July 16, 2005
Biweekly docetaxel-irinotecan treatment with filgrastim support is highly active in antracycline-Paclitaxel-refractory breast cancer patientsGiuseppe Frasci, Giuseppe D'Aiuto, Renato Thomas, et al.Oncology|July 16, 2005
Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumorsLuisa Barzon, Monia Pacenti, Giulia Masi, et al.Pageof 528